Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAVOR: Favipiravir in Uncomplicated Influenza
NCT01728753Phase 2Completed
- Sponsor
- MDVI, LLC
- Start
- Nov 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of favipiravir in influenza, sponsored by MDVI, LLC. Started Nov 2012; status: completed.
02
Drugs
favipiravir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01728753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728753.